STAT3 as a potential therapeutic target in ALDH+ and CD44+/CD24+ stem cell-like pancreatic cancer cells
Li Lin(First Affiliated Hospital of Chongqing Medical University), Jiayuh Lin(Nationwide Children's Hospital)
Cited by 69
Related Papers
Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
|Cancer Research|2010|233
Stat3 activation in human endometrial and cervical cancers
|British Journal of Cancer|2007|164
Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer
|British Journal of Cancer|2005|150
LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model
|British Journal of Cancer|2009|93